市场调查报告书
商品编码
1256375
联网药物输送设备市场 - 按设备按技术按应用按最终用途预测 2023-2032 年Connected Drug Delivery Devices Market - By Device, By Technology, By Application, By End-use & Forecast, 2023 - 2032 |
由于机器学习和人工智能 (AI) 等技术在医疗保健和药物输送领域的应用越来越广泛,预计联网药物输送设备市场到 2032 年将取得显着增长。
此外,实时数据在医疗保健领域日益重要也将推动市场扩张。 此外,市场参与者采取的一些将先进技术融入其设备的举措将推动业务增长。
例如,Becton Dickinson (BD) 已与 Biocorp 签署协议,在註射器中使用近场通信标籤。 该协议将把 Biocorp 的 Injay 设备整合到 UltraSafePlus 预装注射器中,提供增强的数字连接,可用于存储注射日期、批号和有效期等信息。
总体而言,互联给药设备行业按设备、技术、应用、最终用途和区域进行细分。
在设备方面,集成设备领域将在 2023 年至 2032 年期间呈现大幅增长。 慢性病患病率的上升、健康和疾病意识的提高、电信行业的崛起以及政府举措的增加预计将在未来几年推动市场扩张。
在技术方面,Wi-Fi 技术领域预计到 2032 年的复合年增长率将达到 28.5%。 不断创新导致医疗设备采用最新技术的情况有所增加。 此外,消费者对用于跟踪每日药物摄入量的几种连接药物输送设备技术的认识不断提高,将进一步推动对内置 WiFi 的连接药物输送设备的需求。
按应用划分,到 2022 年,过敏反应部分的收入将超过 3100 万美元。 由于在过敏反应患者中越来越多地使用连接的药物输送设备进行快速给药,预计该细分市场将出现显着增长。 过敏反应病例的增加将进一步促进整个市场的增长。 欧洲数据显示,每年每 10 万人因各种原因引起的过敏反应发生率为 1.5 至 7.9 例。
从最终用途的角度来看,家庭护理领域将在 2022 年占据重要的市场份额。 该设备的不断发展使其使用变得简单方便。 此外,家庭护理中对自我管理疗法的日益偏好将推动该行业的发展。
按地区划分,亚太地区的互联给药设备市场预计在整个预测期内都将增长。 製药行业的持续增长将推动市场的增长,因为它为新产品和先进产品提供了有利可图的机会。 此外,越来越多地采用新技术和政府加大力度支持製药业的发展也将支持市场的发展。
Connected Drug Delivery Devices Market is anticipated to garner substantial gains through 2032 owing to the increasing adoption of technologies such as machine learning and artificial intelligence (AI) in healthcare and drug delivery. Besides, the rising importance of real-time data across the healthcare sector will propel the market expansion. In addition, numerous initiatives taken up by market players to incorporate advanced technology in devices will promote the business growth.
Beckton Dickinson (BD), for instance, inked a deal with Biocorp to leverage its near-field communication tags in injectable devices. The deal would see Biocorp's Injay device incorporated in UltraSafePlus prefilled syringes, offering them increased digital connectivity that can be used to accumulate information such as injection time and date, batch number, and expiration date.
Overall, the connected drug delivery devices industry is segmented in terms of device, technology, application, end-use and region.
Based on devices, the integrated devices segment will showcase considerable growth during 2023-2032. The increasing prevalence of chronic diseases, rising awareness regarding health and illness, rising telecommunication industry, and surging government initiatives will propel the market expansion during the ensuing years.
Considering the technology, the Wi-Fi technology segment is anticipated to depict over 28.5% CAGR through 2032. Constant innovations have resulted in the increasing adoption of the latest technologies in medical devices. Besides, the rising consumer awareness regarding several connected drug delivery device technologies to track their daily medication will further drive the demand for WiFi embed connected drug delivery devices.
By application, the anaphylaxis segment accounted for more than USD 31 million in 2022. The segment will see huge growth owing to the increasing use of connected drug delivery devices in anaphylaxis patients for quick drug administration. Increasing cases of anaphylaxis would further benefit the overall market growth. European data depicted that the incidence rates for all-causes of anaphylaxis vary between 1.5 to 7.9 per 100,000 person per year.
In terms of end-use, the homecare settings segment held a considerable market share in 2022. Constant device development have made their use easy and convenient. Furthermore, an increasing preference for self-administered therapy at homecare will drive the industry growth.
Geographically, the Asia Pacific connected drug delivery devices market will grow throughout the forecast period. The constantly increasing pharmaceutical industry will assist the market progression as it offers lucrative opportunities for new and advanced products. Besides, the increasing adoption of new technologies and rising government initiatives for supporting the growth of the pharma industry will boost market development.